This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Inventor Spotlight: Yoshio Arakawa
Introduction
Yoshio Arakawa is a notable inventor hailing from Kyoto, Japan, known for his contributions to the field of chemistry, specifically concerning reverse hydroxamic acid derivatives. With a unique understanding of chemical compounds and their applications, he has made significant strides in pharmaceutical research.
Latest Patents
Arakawa holds a patent for reverse hydroxamic acid derivatives, which are characterized by a specific structure represented by general formulas (Ia) and (I). These compounds are designed to target Tumor Necrosis Factor-alpha converting enzyme (TACE) inhibitory activity, showcasing his innovative approach to addressing health-related challenges through chemical solutions.
Career Highlights
Yoshio Arakawa works at Kaken Pharmaceutical Company, Ltd., where his research has significantly impacted pharmaceutical development. His work emphasizes the intersection of chemistry and medicine, contributing to advancements in therapeutic agents.
Collaborations
Throughout his career, Arakawa has collaborated with esteemed coworkers, including Masanao Shimano and Noriyuki Kamei. Their teamwork exemplifies the collaborative spirit often found in research institutions, fostering an environment conducive to innovation and discovery.
Conclusion
Yoshio Arakawa's journey as an inventor underscores the importance of innovation in the pharmaceutical industry. His patent on reverse hydroxamic acid derivatives is a testament to his dedication to enhancing medical technology and offers promising avenues for further research and application.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
